Lung & Thoracic Oncology

Lung and thoracic malignancies remain major areas of cancer research and clinical innovation. This session covers advances in the biology, diagnosis, staging, treatment, and management of lung cancer and other thoracic tumors, with emphasis on targeted therapy, immunotherapy, molecular testing, and multidisciplinary care.

Abstract Scope and Participation

Submissions may address non-small cell lung cancer, small cell lung cancer, mesothelioma, thoracic tumors, molecular alterations, screening, imaging, surgery, radiation, targeted therapies, immunotherapy, and treatment resistance. Thoracic oncologists, pulmonologists, surgeons, researchers, radiologists, and multidisciplinary professionals are welcome.